National Jewish Health

According to the National Jewish Health consolidated audit of June 30, 2022 (Note 1(a), Corporate Organization, Organization re: Joint Ventures):

"Effective December 2013, National Jewish Health formed a limited liability corporation in a joint venture with Icahn School of Medicine doing business as the Mount Sinai – National Jewish Respiratory Institute to oversee the creation and operations of a joint respiratory institute at various sites in the Mount Sinai integrated health care system in New York City, New York.

Effective August 2014, National Jewish Health entered into a joint operating agreement with Intermountain Healthcare (formerly Sisters of Charity of Leavenworth (SCL) Health)/St. Joseph Hospital for the joint management and operation of National Jewish Health's in-state patient care and St. Joseph Hospital. The new entity is overseen by a Board of Directors with representation from both entities. 

Effective April 2017, National Jewish Health formed a limited liability corporation in a joint venture with Thomas Jefferson University doing a business as the Jane and Leonard Korman Jefferson Health | National Jewish Health Respiratory Institute to oversee the development and operations of a joint respiratory institute at various sites in the Jefferson Health System in Philadelphia, Pennsylvania."

According to the National Jewish Health consolidated audit of June 30, 2022 (Note 19, Related-party Transactions):

"National Jewish Health from time-to-time in the normal course of business and within the guidelines of its conflict of interest policy, has entered into transactions with companies for which certain members of the companies' management also serve on the board of National Jewish Health. Management believes prices paid by National Jewish Health have been equal to or less than the prices that would have been paid in transactions with parties not related to National Jewish Health."

According to the National Jewish Health (NJH) tax filing for the fiscal year ended June 30, 2022, NJH reports for Business Transactions Involving Interested Persons (IRS Form 990 Schedule L, Part IV)

(1) A transaction in the amount of $197,700 involving Lisa Cicutto, Spouse of EVP of Academic Affairs. The transaction is described as: "Salary"

(2) A transaction in the amount of $43,095 involving Jane Baer, Child member of the board of directors . The transaction is described as: "Salary"

According to the National Jewish Health tax filing for the fiscal year ended June 30, 2022, NJH reports receiving contributions of non-cash items on which it placed a value of $180,209 (IRS Form 990, Schedule M).

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the National Jewish Health (NJH) tax filing for the fiscal year ended June 30, 2022, NJH reports re: Compensation Information, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II):

NJH reports providing "bonus & incentive compensation" during 2021 to fourteen individuals. Michael S. Salem M.D., President, CEO, & Board member, received $727,650 of bonus and incentive compensation, with a total reported compensation of $2,020,146. The remaining thirteen individuals received $15,000 to $216,300 with total compensation ranging from $320,150 to $918,672.